Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine

Pediatrics

Volumn 102, Issue 6, 1998, Pages 1483-1491

  Halsey, N A ^a   Abramson, J S ^a   Chesney, P J ^a   Fisher, M C ^a   Gerber, M A ^a   Marcy, S M ^a   Murray, D L ^a   Overturf, G D ^a   Prober, C G ^a   Saari, T N ^a   Weiner, L B ^a   Whitley, R J ^a   Baker, C ^a   Peter, G ^a   Pickering, L K ^a   Hirsch, A ^a   Jacobs, R F ^a   MacDonald, N E ^a   Schwartz, B ^a   Orenstein, W A ^a   Hardegree, M C ^a   Rabinovich, N R ^a   Breiman, R F ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; ORAL POLIOMYELITIS VACCINE; ORAL REHYDRATION SOLUTION; PLACEBO; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE;

ARTICLE; CHILD; CHILD HOSPITALIZATION; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG FEVER; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN ROTAVIRUS; IMMUNIZATION; INFANT; LICENSING; ORAL DRUG ADMINISTRATION; ORAL REHYDRATION THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES; VACCINATION; VIRUS INFECTION;

EID: 0031741756     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.102.6.1483     Document Type: Article

References (73)

1. Brandt CD, Kim HW, Rodriguez JO, et al. Pediatric viral gastroenteritis during eight years of study. J Clin Microbiol. 1983;18:71-78
2. Glass RI, Kilgore PE, Holman RC, et al. The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. J Infect Dis. 1996;174(suppl 1):S5-S11
3. Jin S, Kilgore PE, Holman RC, et al. Trends in hospitalizations for diarrhea in United States children from 1979 through 1992: estimates of the morbidity associated with rotavirus. Pediatr Infect Dis J. 1996;15: 397-404
4. Torok TJ, Kilgore PE, Clarke MJ, et al. Visualizing geographic and temporal trends in rotavirus activity in the United States, 1991 to 1996. Pediatr Infect Dis J. 1997;16:941-946
5. Parashar UD, Holman RC, Clarke MJ, Bresee JS, Glass RI. Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus specific diagnostic code. J Infect Dis. 1998;177:13-17
6. Midthun K, Kapikian AZ. Rotavirus vaccines: an overview. Clin Microbiol Rev. 1996;9:423-434
7. Bern C, Martines J, de Zoysa I, Glass RI. The magnitude of the global problem of diarrhoeal disease: a ten year update. Bull WHO. 1992;70: 705-714
8. Avery ME, Synder JD. Oral therapy for acute diarrhea - the underused simple solution. N Engl J Med. 1990;323:891-894
9. Duggan C, Santosham M, Glass RI. The management of acute diarrhea in children: oral rehydration, maintenance, and nutritional therapy. MMWR Morb Mortal Wkly Rep. 1992;41(RR-16):1-20
10. American Academy of Pediatrics, Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis. Practice parameter: the management of acute gastroenteritis in young children. Pediatrics. 1996;97:424-435
11. Santosham M, Keenan EM, Tulloch J, Broun D, Glass R. Oral rehydration therapy for diarrhea: an example of reverse transfer of technology. Pediatrics. 1997;100(5). URL: http://www.pediatrics.org/cgi/content/ full/100/5/e10
12. Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA, US Rotavirus Vaccine Efficacy Group. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. JAMA. 1995;273: 1191-1196
13. Rennels MB, Glass RI, Dennehy PH, et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines-report of the National Multicenter Trial. Pediatrics. 1996;97:7-13
14. Joensuu J, Koskenniemi E, Pang XL, Vesikari T. Randomized placebo-controlled trial of rhesus human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet. 1997;350:1205-1209
15. Perez-Schael I, Guntinas MJ, Perez M, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med. 1997;337:1181-1187
16. Santosham M, Moulton LH, Reid R, et al. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr. 1997;131:632-638
17. Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection: a prospective longitudinal study in young children. N Engl J Med. 1983;309:72-76
18. Bishop R, Lund J, Cipriani E, et al. Clinical serological and intestinal immune responses to rotavirus infection of humans. Med Virol. 1990;9: 85-109
19. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med. 1996;335: 1022-1028
20. Pickering LK, Bartlett AV III, Reves RR, Morrow A. Asymptomatic excretion of rotavirus before and after rotavirus diarrhea in children in day care centers. J Pediatr. 1988;112:361-365
21. Wilde J, Van R, Pickering L, Eiden J, Yolken R. Detection of rotaviruses in the day care environment by reverse transcriptase polymerase chain reaction. J Infect Dis. 1992;166:507-511
22. Pickering LK, Evans DG, DuPont HL, Vollett JJ, Evans DJ. Diarrhea caused by Shigella, rotavirus and Giardia in day care centers: prospective study. J Pediatr. 1981;99:51-56
23. O'Ryan ML, Matson DO, Estes MK, Bartlett AV, Pickering LK. Molecular epidemiology of rotavirus in children attending day care centers in Houston. J Infect Dis. 1990;162:810-816
24. Gentsch JR, Woods PA, Ramachandran M, et al. Review of G and P typing results from a global collection of strains: implications for vaccine development. J Infect Dis. 1996;174(suppl 1):S30-S36
25. Matson DO, Estes MK. Impact of rotavirus infection at a large pediatric hospital. J Infect Dis. 1990;162:598-604
26. Smith JC, Haddix AC, Teutsch SM, Glass RI. Cost-effectiveness analysis of a rotavirus immunization program for the United States. Pediatrics. 1995;96:609-615
27. Tucker AW, Bresee JS, Haddix AC, Holman RC, Glass RI. Cost-effectiveness analysis of a rotavirus vaccine program in the United States. JAMA. 1998;279:1371-1376
28. Kilgore PE, Holman RC, Clarke MJ, Glass RI. Trends of diarrheal disease-associated mortality in US children, 1968 through 1991. JAMA. 1995;274:1143-1148
29. LeBaron CW, Lew J, Glass RI, Weber JM, Ruiz-Palacios GM. Annual rotavirus epidemic patterns in North America: results of a five-year retrospective survey of 88 centers in Canada, Mexico, and the United States. JAMA. 1990;264:983-988
30. Rodriguez WJ, Kim HW, Arrobio JO, et al. Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children. J Pediatr. 1977;91:188-193
31. Rodriguez WJ, Kim HW, Brandt CD, et al. Rotavirus gastroenteritis in the Washington, DC area: incidence of cases resulting in admission to the hospital. Am J Dis Child. 1980;134:777-779
32. Gurwith M, Wenman W, Gurwith D, Brunton J, Feltham S, Greenberg H. Diarrhea among infants and young children in Canada: a longitudinal study in three northern communities. J Infect Dis. 1983;147:685-692
33. Gurwith M, Wenman W, Hinde D, Feltham S, Greenberg H. A prospective study of rotavirus infection in infants and young children. J Infect Dis. 1981;144:218-224
34. Duffy LC, Riepenhoff-Talty M, Byers TE, et al. Modulation of rotavirus enteritis during breast feeding: implications on alterations in the intestine bacterial flora. Am J Dis Child. 1986;140:1164-1168
35. Newburg DS, Peterson JA, Ruiz-Palacios GM, et al. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet. 1998;351:1160-1164
36. Ramachandran M, Vij A, Kumar R, et al. Lack of maternal antibodies to P serotypes may predispose neonates to infections with unusual rotavirus strains. Clin Diag Lab Immunol. 1998;5:527-530
37. Cook SM, Glass RI, LeBaron CW, Ho MS. Global seasonality of rotavirus infections. Bull WHO. 1990;68:171-177
38. Ushijima H, Xin KQ, Nishimura S, Morikawa S, Abe T. Detection and sequencing of rotavirus VP7 gene from human materials (stools, sera, cerebrospinal fluids, and throat swabs) by reverse transcription and PCR. J Clin Microbiol. 1994;32:2893-2897
39. Velazquez FR, Calva JJ, Guerrero ML, et al. Cohort study of rotavirus serotype patterns in syrnptomatic and asymptomatic infections in Mexican children. Pediatr Infect Dis J. 1993;12:54-61
40. Rodriguez WJ, Kim HW, Brandt CD, et al. Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: clinical and epidemiologic observations. Pediatr Infect Dis J. 1987;6:170-176
41. Saulsbury FT, Winkelstein JA, Yolken RH. Chronic rotavirus infection in immunodeficiency. J Pediatr. 1980;97:61-65
42. Gilger MA, Matson DO, Conner ME, Rosenblatt HM, Finegold MF, Estes MK. Extraintestinal spread of rotavirus infections in children with immunodeficiency. J Pediatr. 1992;120:912-917
43. Parashar UD, Kilgore PE, Holman RC, Clarke MJ, Bresee JS, Glass RI. Diarrhea mortality in US infants: influence of birth weight on risk factors for death. Arch Pediatr Adolesc Med. 1998;152:47-51
44. Cravioto A, Reyes RE, Trujillo F, et al. Risk of diarrhea during the first year of life associated with initial and subsequent colonization by specific enteropathogens. Am J Epidemiol. 1990;131:886-904
45. Reves RR, Hossain MM, Midthun K, et al. An observational study of naturally acquired immunity to rotaviral diarrhea in a cohort of 363 Egyptian children: calculation of risk for second episodes using age-specific person-years of observation. Am J Epidemiol. 1989;130: 981-988
46. Matson DO, O'Ryan ML, Herrer I, Pickering LK, Estes MK. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J Infect Dis. 1993;167:577-583
47. O'Ryan ML, Matson DO, Estes MK, Pickering LK. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J Infect Dis. 1994;169:504-511
48. Offit PA. Host factors associated with protection against rotavirus disease: the skies are clearing. J Infect Dis. 1996;174(suppl 1):S59-64
49. Jayashree S, Bhan MK, Kumar R, Raj P, Glass R, Bhandari N. Serum and salivary antibodies as indicators of rotavirus infection in neonates. J Infect Dis. 1988;158:1117-1120
50. Matsui SM, Mackow ER, Greenberg HB. Molecular determinant of rotavirus neutralization and protection. Adv Virus Res. 1989;36: 181-214
51. Green KY, Taniguchi K, Mackow ER, Kapikian AZ. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development. J Infect Dis. 1990;161:667-679
52. Ward RL, Bernstein DI. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRv vaccines. US Rotavirus Vaccine Efficacy Group. Vaccine. 1995;13: 1226-1232
53. Ward RL. Mechanism of protection against rotavirus in humans and mice. J Infect Dis. 1996;174(suppl 1)S51-S58
54. Vesikari T, Ruuska T, Green KY, Flores J, Kapikian AZ. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity. Pediatr Infect Dis J. 1992;11:535-542
55. Vesikari T. Rotavirus vaccines against diarrhoeal disease. Lancet. 1997; 350:1538-1541
56. Kapikian AZ, Hoshino Y, Chanock RM, Perez-Schael I. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis. 1996;174(suppl 1):S65-S72
57. Ing D, Glass RI, Woods PA, et al. Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine. Am J Dis Child. 1991;145:892-897
58. Pichichero ME. Effect of breast-feeding on oral rhesus rotavirus vaccine seroconversion: a metaanalysis. J Infect Dis. 1990;162:753-755
59. Rennels MB, Wasserman SS, Glass RI, Keane VA, US Rotavirus Vaccine Efficacy Group. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. Pediatrics. 1995;96:1132-1136
60. Lanata CF, Midthun K, Black RE, et al. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J Infect Dis. 1996;174: 268-275
61. Linhares AC, Gabbay YB, Mascarenhas JDP, et al. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil. Bull WHO. 1996;74:491-500
62. Dagan R, Kassis I, Sarov B, et al. Safety and immunogenicity of oral tetravalent human-rhesus reassortant rotavirus in neonates. Pediatr Infect Dis J. 1992;11:991-996
63. Dennehy PH, Rodgers GC Jr, Ward RL, Markwick AJ, Mark M, Zito ET, US Rhesus Rotavirus Vaccine Study Group. Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. Pediatr Infect Dis J. 1996;15:1012-1018
64. Joensuu J. Koskenniemi E, Vesikari T. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants. Pedintr Infect Dis J. 1998;17:334-340
65. Oshitani H, Kasolo FC, Mpabalwani M, et al. Association of rotavirus and human immunodeficiency virus infection in children hospitalized with acute diarrhea, Lusaka, Zambia. J Infect Dis. 1994;169: 897-900
66. Ward RL, Dinsmore AM, Goldberg G, Sander DS, Rappaport RS, Zito ET. Shedding of rotavirus following administration of the tetravalent rhesus rotavirus vaccine. Pediatr Infect Dis J. 1998;17:386-390
67. Wright PF, King J, Araki K, et al. Simultaneous administration of two human rhesus rotavirus reassortant strains of VP7 serotypes 1 and 2 specificity to infants and young children. J Infect Dis. 1991;164:271-276
68. Rennels MB, Ward RL, Mack ME, Zito ET, US Rotavirus Vaccine Efficacy Group. Concurrent oral poliovirus and rhesus-human reassortant rotavirus association: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. J Infect Dis. 1996;173:306-313
69. Markavick AL, Rennels MB, Zito ET, et al. Oral tetravalent rotavirus vaccine can be successfully coadministered with oral poliovirus vaccine and a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine. Pediatr Infect Dis J. 1998;17:913-918
70. Griffiths RI, Anderson GF, Rowe NR, et al. Economic impact of immu-nization against rotavirus gastroenteritis. Evidence from a clinical trial. Arch Pediatr Adolesc Med. 1995;149:407-414
71. American Academy of Pediatrics, Committee on Pediatric AIDS. Evaluation and medical treatment of the HIV-exposed infant. Pediatrics. 1997;99:909-917
72. Clark HF, Offit PA, Ellis RW, et al. The development of multivalent bovine rotavirus (Strain WC3) reassortant vaccine for infants. J Infect Dis. 1996;174(suppl 1):S73-S80
73. Pickering LK, Morrow AL, Herrera I, et al. Effect of maternal rotavirus immunization on milk and serum antibody titers. J Infect Dis. 1995;172: 723-728